Oramed Pharmaceuticals Inc. (ORMP.TA)

ILA 954.6

(1.77%)

Gross Profit Summary of Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc.'s latest annual gross profit in 2022 was 9.5 Million USD , up 12.93% from previous year.
Oramed Pharmaceuticals Inc.'s latest quarterly gross profit in 2023 Q3 was -206.31 Thousand USD , down -108.93% from previous quarter.
Oramed Pharmaceuticals Inc. reported a annual gross profit of 8.41 Million USD in annual gross profit 2021, down -7.41% from previous year.
Oramed Pharmaceuticals Inc. reported a annual gross profit of 9.08 Million USD in annual gross profit 2020, down -1.48% from previous year.
Oramed Pharmaceuticals Inc. reported a quarterly gross profit of 2.26 Million USD for 2023 Q1, down -5.31% from previous quarter.
Oramed Pharmaceuticals Inc. reported a quarterly gross profit of 2.31 Million USD for 2023 Q2, up 1.9% from previous quarter.

Annual Gross Profit Chart of Oramed Pharmaceuticals Inc. (2022 - 2012)

Historical Annual Gross Profit of Oramed Pharmaceuticals Inc. (2022 - 2012)

Year	Gross Profit	Gross Profit Growth
2022	9.5 Million USD	12.93%
2021	8.41 Million USD	-7.41%
2020	9.08 Million USD	-1.48%
2019	9.22 Million USD	1.35%
2018	9.1 Million USD	11.86%
2017	8.13 Million USD	1324.71%
2016	571.21 Thousand USD	3729.73%
2015	-15.73 Thousand USD	0.0%
2014	- USD	0.0%
2013	- USD	0.0%
2012	- USD	0.0%

Year	Gross Profit	Gross Profit Growth
2023 Q3	-206.31 Thousand USD	-108.93%
2023 Q1	2.26 Million USD	-5.31%
2023 Q2	2.31 Million USD	1.9%
2022 Q3	2.43 Million USD	3.31%
2022 FY	9.5 Million USD	12.93%
2022 Q1	2.12 Million USD	-0.75%
2022 Q2	2.35 Million USD	10.77%
2022 Q4	2.39 Million USD	-1.54%
2021 Q3	2.19 Million USD	-0.61%
2021 Q4	2.14 Million USD	-2.62%
2021 Q1	2.2 Million USD	-1.27%
2021 Q2	2.21 Million ILA	0.51%
2021 FY	8.41 Million USD	-7.41%
2020 Q3	2.28 Million USD	-4.48%
2020 Q2	2.39 Million USD	2.22%
2020 Q4	2.22 Million USD	-2.4%
2020 Q1	2.33 Million USD	-0.15%
2020 FY	9.08 Million USD	-1.48%
2019 Q1	2.21 Million USD	-6.79%
2019 Q2	2.47 Million USD	11.65%
2019 FY	9.22 Million USD	1.35%
2019 Q4	2.34 Million USD	-2.67%
2019 Q3	2.4 Million USD	-2.65%
2018 Q4	2.37 Million USD	6.8%
2018 Q1	2.1 Million USD	-1.62%
2018 Q3	2.22 Million USD	17.51%
2018 Q2	1.89 Million USD	-9.88%
2018 FY	9.1 Million USD	11.86%
2017 Q2	2.18 Million USD	-1.82%
2017 Q4	2.13 Million USD	-3.6%
2017 FY	8.13 Million USD	1324.71%
2017 Q1	2.22 Million USD	37.27%
2017 Q3	2.21 Million USD	1.42%
2016 Q3	-472.07 Thousand USD	-179.02%
2016 FY	571.21 Thousand USD	3729.73%
2016 Q4	1.62 Million USD	443.27%
2016 Q2	597.38 Thousand USD	26.33%
2016 Q1	472.87 Thousand USD	0.0%
2015 Q2	- USD	0.0%
2015 Q1	- USD	0.0%
2015 FY	-15.73 Thousand USD	0.0%
2015 Q4	- USD	0.0%
2015 Q3	- USD	0.0%
2014 Q2	- USD	0.0%
2014 Q1	- USD	0.0%
2014 Q3	- USD	0.0%
2014 Q4	- USD	0.0%
2014 FY	- USD	0.0%
2013 FY	- USD	0.0%
2013 Q1	- USD	0.0%
2013 Q3	- USD	0.0%
2013 Q4	- USD	0.0%
2013 Q2	- USD	0.0%
2012 Q3	- USD	0.0%
2012 Q4	- USD	0.0%
2012 FY	- USD	0.0%

Peer Gross Profit Comparison of Oramed Pharmaceuticals Inc.

Name	Gross Profit	Gross Profit Difference